VVP
VIVO

Venture Visionary Partners’s Meridian Bioscience Inc VIVO Stock Holding History

Venture Visionary Partners’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,092
Closed -$63.6K – 1663
2022
Q2 		$63.6K Buy
+2,092
New +$56.6K ﹤0.01% 734

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Venture Visionary Partners's VIVO Position: Q3 2022 in Review

Venture Visionary Partners sold out of Meridian Bioscience Inc (VIVO) in Q3 2022, closing a stake of 2,092 shares — an estimated $63.6K sold.

Venture Visionary Partners first reported a position in VIVO in Q2 2022 and held it in 1 quarter. The position peaked at $63.6K in Q2 2022. 203 funds tracked by Wall St. Rank hold VIVO as of Q3 2022.

  • Venture Visionary Partners reported no remaining Meridian Bioscience Inc position as of Q3 2022 after selling out during the quarter.
  • Venture Visionary Partners sold 2,092 Meridian Bioscience Inc shares in Q3 2022, an estimated $63.6K.
  • Venture Visionary Partners first reported a position in Meridian Bioscience Inc in Q2 2022 and held it in 1 quarter.
  • Venture Visionary Partners's Meridian Bioscience Inc position peaked at $63.6K in Q2 2022.
  • 203 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2022.

Based on Venture Visionary Partners's 13F filing for Q3 2022, filed 14 Nov 2022.